Erika L. Pearce

Last updated
Erika Pearce
Born1972 (age 50–51)
North Fork, New York, USA
Alma materBSc, Cornell University
PhD, University of Pennsylvania
Awards
Scientific career
Fields
Institutions
Thesis Development of CD8 T cell responses (2005)
Website www.ie-freiburg.mpg.de/pearce

Erika L. Pearce is an American immunologist. She is the Bloomberg Distinguished Professor at the Johns Hopkins University after serving as director and a scientific member at Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany. Her work investigates the connection between metabolism and immune cell function with a particular focus on the regulation of T-cells. In 2018, she was awarded the Leibniz Prize for her "outstanding work in metabolism and inflammation research."

Contents

Early life and education

Pearce was born in 1972, [1] and grew up in North Fork, Long Island, New York. [2] She completed her Bachelor of Science degree at Cornell University in 1998 and earned her PhD in cell and molecular biology from the University of Pennsylvania in 2005. [3] While completing her postdoctoral studies at the University of Pennsylvania, Pearce began her research into how cellular metabolic processes govern immune responses to infection and cancer. [4]

Career

Upon completing her postdoctoral studies, Pearce joined the Trudeau Institute in New York City from 2009 until 2011. She left the non-profit in 2011 to become an assistant professor in the Department of Pathology and Immunology at the Washington University School of Medicine (WUSM) in St. Louis. [1] During her tenure at WUSM, Pearce expanded on her earlier research into memory T cells. In 2012, her research team found that the production of additional mitochondria is triggered by interleukin-15. She also found that genetically manipulating T cell's mitochondria could cause a higher percentage of undifferentiated T cells to become memory cells. [5] Pearce and her colleagues also found evidence that suggested cancer cells could disable T cells ability to fight off tumors and some kinds of infection. Her research team found that withholding sugar from T cells, the cells no longer produced interferon gamma. [6] In March 2014, Pearce was promoted to the rank of associate professor of pathology and immunology at WUSM. [7] In her new role, Pearce received two grants to assist her research into cellular metabolism in immunity to infection. She received a grant from the Burroughs Wellcome Fund [8] and the National Cancer Institute of the National Institutes of Health. [9]

Pearce left North America in September 2015 to become the director and a scientific member at Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany. [10] In 2018, she was awarded the Leibniz Prize for her "outstanding work in metabolism and inflammation research." [1] Pearce returned to the United States in 2022 to become the Bloomberg Distinguished Professor at Johns Hopkins University. [11]

Publications

As of 2021, Pearce has more than 18,000 citations in Google Scholar and an h-index of 49. [12]

Highly cited articles (more than 1000 citations)

See also

Related Research Articles

<span class="mw-page-title-main">Inflammation</span> Physical effects resulting from activation of the immune system

Inflammation is part of the complex biological response of body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants, and is a protective response involving immune cells, blood vessels, and molecular mediators. The function of inflammation is to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and initiate tissue repair.

<span class="mw-page-title-main">Aneuploidy</span> Presence of an abnormal number of chromosomes in a cell

Aneuploidy is the presence of an abnormal number of chromosomes in a cell, for example a human cell having 45 or 47 chromosomes instead of the usual 46. It does not include a difference of one or more complete sets of chromosomes. A cell with any number of complete chromosome sets is called a euploid cell.

<span class="mw-page-title-main">Liver disease</span> Medical condition

Liver disease, or hepatic disease, is any of many diseases of the liver. If long-lasting it is termed chronic liver disease. Although the diseases differ in detail, liver diseases often have features in common.

Ira Mellman is an American cell biologist who discovered endosomes. He serves as Vice President of Research Oncology at Genentech in South San Francisco, California.

<span class="mw-page-title-main">Indoleamine 2,3-dioxygenase</span> Mammalian protein found in Homo sapiens

Indoleamine-pyrrole 2,3-dioxygenase (IDO or INDO EC 1.13.11.52) is a heme-containing enzyme physiologically expressed in a number of tissues and cells, such as the small intestine, lungs, female genital tract or placenta. In humans is encoded by the IDO1 gene. IDO is involved in tryptophan metabolism. It is one of three enzymes that catalyze the first and rate-limiting step in the kynurenine pathway, the O2-dependent oxidation of L-tryptophan to N-formylkynurenine, the others being indolamine-2,3-dioxygenase 2 (IDO2) and tryptophan 2,3-dioxygenase (TDO). IDO is an important part of the immune system and plays a part in natural defense against various pathogens. It is produced by the cells in response to inflammation and has an immunosuppressive function because of its ability to limit T-cell function and engage mechanisms of immune tolerance. Emerging evidence suggests that IDO becomes activated during tumor development, helping malignant cells escape eradication by the immune system. Expression of IDO has been described in a number of types of cancer, such as acute myeloid leukemia, ovarian cancer or colorectal cancer. IDO is part of the malignant transformation process and plays a key role in suppressing the anti-tumor immune response in the body, so inhibiting it could increase the effect of chemotherapy as well as other immunotherapeutic protocols. Furthermore, there is data implicating a role for IDO1 in the modulation of vascular tone in conditions of inflammation via a novel pathway involving singlet oxygen.

<span class="mw-page-title-main">Max Planck Institute of Immunobiology and Epigenetics</span>

The Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany is an interdisciplinary research institute that conducts basic research in modern immunobiology, developmental biology and epigenetics. It was founded in 1961 as the Max Planck Institute of Immunobiology and is one of 86 institutions of the Max Planck Society. Originally named the Max Planck Institute of Immunobiology, it was renamed to its current name in 2010 as it widened its research thrusts to the study of epigenetics.

Hartmut Wekerle is a German medical scientist and neurobiologist. He is an emeritus director at the Max Planck Institute of Neurobiology and was the head of the department of Neuroimmunology until 2012.

<span class="mw-page-title-main">Siddhartha Mukherjee</span> Indian-American physician, writer b. 1970

Siddhartha Mukherjee is an Indian-American physician, biologist, and author. He is best known for his 2010 book, The Emperor of All Maladies: A Biography of Cancer, that won notable literary prizes including the 2011 Pulitzer Prize for General Non-Fiction, and Guardian First Book Award, among others. The book was listed in the "All-Time 100 Nonfiction Books" by Time magazine in 2011. His 2016 book The Gene: An Intimate History made it to #1 on The New York Times Best Seller list, and was among The New York Times 100 best books of 2016, and a finalist for the Wellcome Trust Prize and the Royal Society Prize for Science Books.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19 and Long COVID.

Zena Werb was a professor and the Vice Chair of Anatomy at the University of California, San Francisco. She was also the co-leader of the Cancer, Immunity, and Microenvironment Program at the Hellen Diller Family Comprehensive Cancer Center and a member of the Executive Committee of the Sabre-Sandler Asthma Basic Research Center at UCSF. Her research focused on features of the microenvironment surrounding cells, with particular interest in the extracellular matrix and the role of its protease enzymes in cell signaling.

<span class="mw-page-title-main">Thomas Jenuwein</span> German scientist

Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.

<span class="mw-page-title-main">Hans-Georg Rammensee</span>

Hans-Georg Rammensee is a German immunologist and cancer researcher. He has been Chair Professor and Head of the Department of Immunology at the University of Tübingen since 1996. Rammensee has contributed essentially to the research fields of MHC biology and tumor immunology and to the development of cancer immunotherapies.

<span class="mw-page-title-main">CD28 family receptor</span> Group of regulatory cell surface receptors

CD28 family receptors are a group of regulatory cell surface receptors expressed on immune cells. The CD28 family in turn is a subgroup of the immunoglobulin superfamily.

Asifa Akhtar is a Pakistani biologist who has made significant contributions to the field of chromosome regulation. She is Senior Group Leader and Director of the Department of Chromatin Regulation at the Max Planck Institute of Immunobiology and Epigenetics. Akhtar was awarded EMBO membership in 2013. She became the first international and female Vice President of the Max Planck Society's Biology and Medicine Section in July 2020.

Miram Merad is a French-Algerian professor in Cancer immunology and the Director of the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY. She is the corecipient of the 2018 William B. Coley Award for Distinguished Research in Basic Immunology and a member of the United States National Academy of Sciences.

Ya-Chi Ho is a Taiwanese infectious disease researcher and Associate Professor of Microbial Pathogenesis and Medicine at Yale University. Her research centers on the interaction between HIV and the host's immune system with the ultimate goal of curing HIV/AIDS.

<span class="mw-page-title-main">Carla V. Rothlin</span> Argentinian immunologist

Carla V. Rothlin is an Argentinian immunologist and Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at Yale University in New Haven, Connecticut. Rothlin is also the co-leader of the Cancer Immunology Program at Yale Cancer Center as well as an Howard Hughes Medical Investigator faculty scholar. Rothlin studies the mechanisms that regulate immune homeostasis and wound repair, with specific interests in cell death recognition, immune checkpoints, and cellular crosstalk in the context of injury and cell turnover. She has made fundamental discoveries about the roles of TAM receptors tyrosine kinase and their ligands in the regulation of inflammation. Rothlin is also a co-founder of the Global Immunotalks, a weekly series of virtual Zoom lectures started in 2020 that brings together scientists from around the world to listen to cutting-edge immunology research from leaders in the field.

<span class="mw-page-title-main">Thomas Boehm (biologist)</span> German immunologist

Thomas Boehm is a German immunologist. He is the Director of the Max Planck Institute for Immunobiology and Epigenetics in Freiburg im Breisgau. He has won a variety of prizes for his research work.

<span class="mw-page-title-main">Oncometabolism</span>

Oncometabolism is the field of study that focuses on the metabolic changes that occur in cells that make up the tumor microenvironment (TME) and accompany oncogenesis and tumor progression toward a neoplastic state.

Kristen Kroll is an American developmental and stem cell biologist and Professor of Developmental Biology at Washington University School of Medicine. Her laboratory studies transcriptional and epigenetic regulation of brain development and its disruption to cause neurodevelopmental disorders.

References

  1. 1 2 3 "Leibniz Prize 2018 for Erika Pearce". Max Planck Institute. December 14, 2017. Retrieved November 21, 2022.
  2. ↑ O’Donnell, Marie Anne (July 2, 2018). "Erika Pearce: Fitting metabolism and immunity together, to a T". Journal of Cell Biology . 21 (7): 2223–2224. doi:10.1083/jcb.201806055. PMC   6028542 . PMID   29921602.
  3. ↑ "Erika L. Pearce, Ph.D." Johns Hopkins University. Retrieved November 21, 2022.
  4. ↑ "Diabetes drug may help fight cancer, mouse study suggests". Canadian Broadcasting Corporation. June 3, 2009. Retrieved November 21, 2022.
  5. ↑ Purdy, Michael C. (January 18, 2012). "Immune system memory cells have trick for self preservation". Washington University in St. Louis. Retrieved November 21, 2022.
  6. ↑ Purdy, Michael C. (June 6, 2013). "Tumors disable immune cells by using up sugar". Washington University in St. Louis. Retrieved November 21, 2022.
  7. ↑ "TRUSTEES GRANT FACULTY PROMOTIONS, TENURE". Washington University in St. Louis. April 21, 2014. Archived from the original on November 22, 2022. Retrieved November 21, 2022.
  8. ↑ Campbell, Russ (June 15, 2014). "BWF Invests $21 Million In Biomedical Research". Burroughs Wellcome Fund . Retrieved November 21, 2022.
  9. ↑ "Medical researcher Pearce receives nearly $1.8 million in grants". Washington University in St. Louis. August 11, 2015. Retrieved November 21, 2022.
  10. ↑ "Erika Pearce – new director at the MPI-IE". Max-Planck-Institute of Immunobiology and Epigenetics. October 12, 2015. Retrieved November 21, 2022.
  11. ↑ Cruickshank, Saralyn (April 6, 2021). "Molecular biologist Erika Pearce joins Johns Hopkins as Bloomberg Distinguished Professor". Johns Hopkins University. Retrieved November 21, 2022.
  12. ↑ Erika L. Pearce publications indexed by Google Scholar
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.